BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,698 | 0.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $1,698 | +15.4% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,472 | +22.6% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,201 | -31.4% | 50,000 | -9.1% | 0.00% | -25.0% |
| Q2 2023 | $1,750 | +5.5% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,658 | -4.8% | 55,000 | +22.2% | 0.00% | -20.0% |
| Q4 2022 | $1,742 | -99.9% | 45,000 | +80.0% | 0.01% | +25.0% |
| Q3 2022 | $1,200,000 | +112.0% | 25,000 | +78.6% | 0.00% | +100.0% |
| Q2 2022 | $566,000 | -39.7% | 14,000 | -11.4% | 0.00% | 0.0% |
| Q1 2022 | $939,000 | -24.3% | 15,800 | +0.6% | 0.00% | -33.3% |
| Q4 2021 | $1,241,000 | -7.0% | 15,700 | +2.6% | 0.00% | -25.0% |
| Q3 2021 | $1,334,000 | +127.3% | 15,300 | +188.7% | 0.00% | +100.0% |
| Q2 2021 | $587,000 | -63.6% | 5,300 | -75.1% | 0.00% | -60.0% |
| Q1 2021 | $1,613,000 | -9.0% | 21,300 | +6.5% | 0.01% | -28.6% |
| Q4 2020 | $1,773,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |